Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Transcenta Announces First Patient Dosed in Phase IIa Study of Claudin18.2 Monoclonal Antibody TST001 Combined with Cisplatin and Gemcitabine for the First Line Treatment of Biliary Tract Cancer 2022-02-28 10:03
Transcenta to Present Two Phase I Clinical Trials of TST001 at Upcoming ASCO GI and IGCC 2022-01-12 15:15
Transcenta Announces the Appointment of Daniel Weng as CFO 2021-12-17 08:30
1 2 3